AIDX
Financials
- Market Capitalization 7.92 M
- Employee 14
- Founded 2000
- CEO N/A
- Website www.2020biolabs.com
- Headquarter Delaware, United States
- FIGI BBG01ZZ5RSY3
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4758 |  AIMD Ainos, Inc. - Common Stock | 1.40 USD | 0.00% | 0.00% | +2.94% | -61.75% | 10.34 M USD | ||
| 4761 |  SINT SiNtx Technologies, Inc. - Common Stock | 1.53 USD | +2.00% | +0.66% | -11.05% | -50.65% | 10.20 M USD | ||
| 4814 |  NVNO enVVeno Medical Corporation - Common Stock | 11.47 USD | +7.20% | +8.21% | +7.30% | +1265.48% | 7.83 M USD | ||
| 4816 |  CODX Co-Diagnostics, Inc. - Common Stock | 1.24 USD | +2.48% | 0.00% | -15.07% | -61.25% | 7.75 M USD |
Frequently asked questions about 20/20 Biolabs, Inc. Common Stock
What is the 20/20 Biolabs, Inc. Common Stock stock price today?
The current price of 20/20 Biolabs, Inc. Common Stock (AIDX) is 0.62. Over the past 24 hours, the stock has changed by 0.00%. Follow the AIDX chart for real-time price dynamics.
What is the stock ticker of 20/20 Biolabs, Inc. Common Stock?
20/20 Biolabs, Inc. Common Stock trades under the ticker AIDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is 20/20 Biolabs, Inc. Common Stock stock going up?
AIDX has changed by +6.90% over the last week, +37.78% over the last month, and -98.76% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of 20/20 Biolabs, Inc. Common Stock?
20/20 Biolabs, Inc. Common Stock currently has a market capitalization of 7.92 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were 20/20 Biolabs, Inc. Common Stock earnings last quarter?
Last quarter, 20/20 Biolabs, Inc. Common Stock reported earnings of -0.26 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was 20/20 Biolabs, Inc. Common Stock revenue for the last quarter?
20/20 Biolabs, Inc. Common Stock reported quarterly revenue of 730.57 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was 20/20 Biolabs, Inc. Common Stock net income for the last quarter?
20/20 Biolabs, Inc. Common Stock reported net income of -1.51 M for the last quarter. The previous quarter showed -2.17 M, which means net income changed by +30.74%.
How many employees does 20/20 Biolabs, Inc. Common Stock have?
As of the latest available data, 20/20 Biolabs, Inc. Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.
What is 20/20 Biolabs, Inc. Common Stock EBITDA?
20/20 Biolabs, Inc. Common Stock EBITDA is -1.23 M, and its EBITDA margin is -168.62%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy 20/20 Biolabs, Inc. Common Stock stock?
You can buy 20/20 Biolabs, Inc. Common Stock (AIDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in 20/20 Biolabs, Inc. Common Stock stock?
Investing in 20/20 Biolabs, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AIDX chart and related analysis on metatrader.com as part of your research.